Wednesday, January 26, 2022
7:30PM – 8:30PM ET
Please note this TeleECHO program is 7:30PM Eastern, 6:30PM Central, 5:30PM Mountain and 4:30PM Pacific.
These live virtual TeleECHO® sessions will be a faculty-led didactic and case-based lecture focusing on the management of patients with hepatocellular carcinoma (HCC).
Robert G. Gish, MD, FAASLD, AGAF, FAST
Principal, Robert G. Gish Consultants, LLC
La Jolla, California
Adjunct Professor of Medicine, University of Nevada, Reno
and University of Nevada, Las Vegas
Medical Director, Hepatitis B Foundation
Adjunct Professor, UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences
San Diego, California
After completing the CME activity, learners should be better able to:
- Evaluate evidence from clinical trials assessing emerging therapies for the treatment of patients with advanced HCC
- Devise strategies to manage the therapy-related AEs associated with guideline-recommended systemic therapies for the treatment of advanced HCC
- Interpret data on biomarkers that may help inform treatment decision making for patients with advanced HCC
This live virtual activity is intended for U.S.-based hematologists/oncologists, hepatologists, gastroenterologists, interventional radiologists, pathologists, and other members of the multidisciplinary oncology team (NPs, PAs, pharmacists) responsible for the care of patients with HCC.
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live virtual activity for a maximum of 1.0 AMA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live virtual activity.
NURSING CREDIT INFORMATION
This program would be beneficial for nurses involved in the management of patients with HCC.
1.0 ANCC Contact Hour
CNE Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.0 contact hour(s) of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact: Med Learning Group at firstname.lastname@example.org.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at email@example.com